These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19159473)

  • 1. Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
    McEwen A; West R
    BMC Public Health; 2009 Jan; 9():28. PubMed ID: 19159473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
    Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A
    Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Real-world' effectiveness of smoking cessation treatments: a population study.
    Kotz D; Brown J; West R
    Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
    Sicras Mainar A; Navarro Artieda R; Díaz Cerezo S; Martí Sánchez B; Sanz De Burgoa V
    Aten Primaria; 2011 Sep; 43(9):482-9. PubMed ID: 21382649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
    Doggrell SA
    Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
    Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.
    Brose LS; West R; Stapleton JA
    Mayo Clin Proc; 2013 Mar; 88(3):226-33. PubMed ID: 23489449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
    Johnson M; Anderson P; Lockhart I
    BMC Fam Pract; 2014 Mar; 15():47. PubMed ID: 24645823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D; Tappenden P; Peters J; Kenjegalieva K
    Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
    Hays JT; Ebbert JO
    Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for preventing weight gain after smoking cessation.
    Farley AC; Hajek P; Lycett D; Aveyard P
    Cochrane Database Syst Rev; 2012 Jan; 1():CD006219. PubMed ID: 22258966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey.
    Kasza KA; Hyland AJ; Borland R; McNeill AD; Bansal-Travers M; Fix BV; Hammond D; Fong GT; Cummings KM
    Addiction; 2013 Jan; 108(1):193-202. PubMed ID: 22891869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009670. PubMed ID: 23235680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
    Stead LF; Koilpillai P; Lancaster T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009670. PubMed ID: 26457723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.